article thumbnail

Gaining Market Access in Emerging Markets – Take Action!

Clarity Engagement Solutions

The process of approval was simple: once the data showed the efficacy, safety and reliability to the regulatory agencies, the drug was approved. Thus, market access involved little engagement with a small set of stakeholders.In Thus, market access involved little engagement with a small set of stakeholders.In

article thumbnail

Gaining Market Access in Emerging Markets – Take Action!

Clarity Engagement Solutions

The process of approval was simple: once the data showed the efficacy, safety and reliability to the regulatory agencies, the drug was approved. Thus, market access involved little engagement with a small set of stakeholders.In Thus, market access involved little engagement with a small set of stakeholders.In – Channel.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Quality first: How pharma can meet injectables demand while staying compliant

Pharmaceutical Technology

This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. The injectable drugs market is currently valued at around $532 billion. Another step is to source the highest quality components available on the market. Several drug development trends are driving injectables demand.

Pharma 52
article thumbnail

Clinical trials in Ukraine: Ensuring supply chain continuity during war

Pharmaceutical Technology

Little by little, clinical trials are coming back to Ukraine,” suggests Pawel Drozd, senior key account manager for clinical trial logistics at Oximio. Oncology remains the highest indication area with eight trials, with ophthalmology next at six. Credit: Oximio. Please check your email to download the Webinar.